SCHEMBL7744200

SCHEMBL7744200

CC(=O)Nc1oc(-c2ccccc2-c2cccc(O)c2)nc1-c1cccs1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.53
FLT1 P17948 1/20 0.53
FLT4 P35916 1/20 0.53
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ABL1 P00519 1/20 0.44
ALOX15 P16050 1/20 0.43
MAPT P10636 2/20 0.43
RXFP1 Q9HBX9 1/20 0.43
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ABCB1 P08183 1/20 0.39
ABCG2 Q9UNQ0 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
FYN P06241 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744781 0.88 ADCY1 (0.47) KDRFLT1FLT4MEN1KMT2A
SCHEMBL7744668 0.87 KDR (0.69) KDRFLT1FLT4ABL1ALOX15
SCHEMBL7744057 0.86 HPGD (0.43) KDRFLT1FLT4MEN1KMT2A
SCHEMBL7744772 0.85 KDR (0.61) KDRFLT1FLT4ABL1ALOX15
SCHEMBL7746642 0.83 KDR (0.55) KDRFLT1FLT4MEN1KMT2A
SCHEMBL7744664 0.83 KDR (0.55) KDRFLT1FLT4MEN1KMT2A
SCHEMBL7739089 0.82 KDR (0.60) KDRFLT1FLT4ABL1ALOX15
SCHEMBL7739080 0.82 KDR (0.62) KDRFLT1FLT4ABL1ALOX15
SCHEMBL7746620 0.82 KDR (0.57) KDRFLT1FLT4MEN1KMT2A
SCHEMBL7739016 0.82 KDR (0.56) KDRFLT1FLT4ABL1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed